SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-027949
Filing Date
2020-05-08
Accepted
2020-05-08 16:48:26
Documents
1
Period of Report
2020-05-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4023
  Complete submission text file 0001209191-20-027949.txt   5403
Mailing Address C/O CARDINAL HEALTH PARTNERS 221 NASSAU STREET PRINCETON NJ 08542
Business Address
CLARKE JOHN K (Reporting) CIK: 0001219015 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37378 | Film No.: 20861344

Mailing Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121 858-731-8389
aTYR PHARMA INC (Issuer) CIK: 0001339970 (see all company filings)

IRS No.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences